Susquehanna International Group’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-121,300
| Closed | -$72.8K | – | 12265 |
|
|
2025
Q3 | $72.8K | Buy |
121,300
+95,400
| +368% | +$44.9K | ﹤0.01% | 11729 |
|
|
2025
Q2 | $8.03K | Buy |
+25,900
| New | +$10K | ﹤0.01% | 12419 |
|
|
2025
Q1 | – | Sell |
-99,300
| Closed | -$85.4K | – | 12409 |
|
|
2024
Q4 | $85.4K | Buy |
99,300
+11,600
| +13% | +$72.7K | ﹤0.01% | 11437 |
|
|
2024
Q3 | $745K | Buy |
87,700
+64,800
| +283% | +$382K | ﹤0.01% | 7504 |
|
|
2024
Q2 | $107K | Sell |
22,900
-17,400
| -43% | -$82.3K | ﹤0.01% | 10982 |
|
|
2024
Q1 | $274K | Buy |
40,300
+23,900
| +146% | +$107K | ﹤0.01% | 9909 |
|
|
2023
Q4 | $54.9K | Buy |
+16,400
| New | +$40.8K | ﹤0.01% | 11678 |
|
|
2022
Q1 | – | Sell |
-44,700
| Closed | -$400K | – | 12922 |
|
|
2021
Q4 | $400K | Sell |
44,700
-38,200
| -46% | -$502K | ﹤0.01% | 9775 |
|
|
2021
Q3 | $1.38M | Buy |
82,900
+20,700
| +33% | +$357K | ﹤0.01% | 6710 |
|
|
2021
Q2 | $1.29M | Buy |
+62,200
| New | +$1.18M | ﹤0.01% | 7041 |
|
|
2021
Q1 | – | Sell |
-87,500
| Closed | -$1.93M | – | 12195 |
|
|
2020
Q4 | $1.93M | Buy |
+87,500
| New | +$1.82M | ﹤0.01% | 5183 |
|
Susquehanna International Group's APLT Position: Q1 2026 in Review
Susquehanna International Group sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 52,692 shares — an estimated $5.27K sold.
Susquehanna International Group first reported a position in APLT in Q3 2020 and held it in 19 quarters. The position peaked at $3.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Susquehanna International Group reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 52,692 Applied Therapeutics shares in Q1 2026, an estimated $5.27K.
- Susquehanna International Group first reported a position in Applied Therapeutics in Q3 2020 and held it in 19 quarters.
- Susquehanna International Group's Applied Therapeutics position peaked at $3.3M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.